Cargando…
The Many Faces of Apomorphine: Lessons from the Past and Challenges for the Future
Apomorphine is now recognized as the oldest antiparkinsonian drug on the market. Though still underused, it is increasingly prescribed in Europe for patients with advanced Parkinson’s disease (PD) with motor fluctuations. However, its history is far from being limited to movement disorders. This pap...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995787/ https://www.ncbi.nlm.nih.gov/pubmed/29546602 http://dx.doi.org/10.1007/s40268-018-0230-3 |